<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Farmacocinética de amicacina en ratones entrenados

cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloUniversidad Nacional de La Plata es
cic.parentTypeArticulo
cic.versioninfo:eu-repo/semantics/publishedVersiones
dc.date.accessioned2016-10-17T17:44:03Z
dc.date.available2016-10-17T17:44:03Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/4440
dc.titleFarmacocinética de amicacina en ratones entrenadoses
dc.typeArtículoes
dcterms.abstractThe aim of the present paper was to determine the blood biochemistry and the pharmacokinetic behavior of amikacin administered to mice with and without physical training. One hundred and forty seven, adult male mice, weighing 25 to 35 gram b.w. were used. Sixty one animals were randomly assigned for Experience 1 (E1) and 86 for Experience 2 (E2). During E1, the mice weretrained swimming 20 minutes a day 5 days a week during 7 weeks. E2 mice remained without training. Blood samples from 75 mice and [n(E1) = 25 and n(E2)= 50] were collected to determine the blood biochemistry. Seventytwo mice [n(E1)= 36 and n(E2)= 36] were administered with a single dose of amikacin by intramuscular route (10 mg/kg b.w.). One blood sample per animal (E1 and E2) was taken postadministration of the antibiotic. For kinetic and statistical analyses, noncompartment model and multifactorial ANOVA were used, respectively. The data for each timepoint was averaged and these values were used to calculate the pharmacokinetics parameters. Statistical differences (P< 0.05) were found in biochemical values (means ± 1 S.D) of creatinekinase (1,266.9 ± 1,181.3 and 66.0 ± 43.3 UI/L) and aspartate aminotransferase (186.2 ± 23.8 and 150.1 ± 80.5 UI/L) in mice with and without training, respectively. Results [Pharmacokinetic parameters (means)]: Maximum plasma concentration (E1) = 10.2 and (E2) = 14.8 μg/mL; time to reach maximum concentration (E1 and E2) = 0.25 h; smallest disposition rate constant (E1) = 0.31 and (E2) = 0.54 h-1; elimination half-life (E1) = 2.2 and (E2) = 1.3 h; area under the curve (E1) = 13.9 and (E2) = 15.6 μg/mL/h. Amikacin concentration-times obtained during E1 and E2 were not statistically different (P > 0.05).en
dcterms.alternativePharmacokinetics of amikacin administered in trained miceen
dcterms.creator.authorRule, Robertoes
dcterms.creator.authorArauz, Sandraes
dcterms.creator.authorProzzi, Guillermoes
dcterms.extentp. 285-289es
dcterms.identifier.urlDocumento completoes
dcterms.isPartOf.issuevol. 39, nº3es
dcterms.isPartOf.seriesActa Bioquimica Clinica Latinoamericanaes
dcterms.issued2005
dcterms.languageEspañoles
dcterms.licenseAttribution-NonCommercial 4.0 International (BY-NC 4.0)es
dcterms.publisherFederación Bioquímica de la Provincia de Buenos Aireses
dcterms.subjectFarmacocinéticaes
dcterms.subjectAmicacinaes
dcterms.subjectCreatina Quinasaes
dcterms.subjectAspartato Aminotransferasases
dcterms.subjectRatoneses
dcterms.subjectactividad físicaes
dcterms.subject.materiaFarmacología y Farmaciaes

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rule_v39n3a03.pdf-PDFA.pdf
Size:
166.91 KB
Format:
Adobe Portable Document Format
Description:
Documento completo